期刊文献+

缬沙坦恢复哮喘大鼠气道肝细胞生长因子的生成及其意义 被引量:3

Effect of valsatan on hepatocyte growth factor in the airways of asthmatic rats
下载PDF
导出
摘要 目的探讨血管紧张素受体拮抗剂(AT1)缬沙坦,对恢复哮喘大鼠气道肝细胞生长因子(HGF)的生成与哮喘气道重塑的关系和意义。方法SD清洁级大鼠32只,体重在100±10g,随机分为4组:A组:正常对照组,B组:卵蛋白(OVA)激发2周组,C组:OVA激发4周组,D组:OVA激发4周后缬沙坦干预组。用免疫组化法测定各组大鼠气道的HGF,AngII和TGF-β1的表达变化,苏木精-伊红染色观察气道病理变化。结果A组HGF较B组有明显差异[(5.49±1.34)%vs(10.69±0.96)%,P<0.05],C组为(11.85±0.87)%,较A组升高(P<0.05),D组为(15.58±1.06)%,较B组、C组升高。AngII和TGF-β1的表达则随着OVA激发时间的延长而增加,在使用缬沙坦后两者都明显下降。经抗原致敏和激活的大鼠气道上皮脱落炎性细胞堆积呈现明显的病理改变,而缬沙坦干预组的病理改变较轻,上皮细胞较完整,炎性细胞和纤维细胞较少。结论①HGF随着气道重塑变化浓度有所改变,说明早期HGF即有保护气道作用,和TGF-β1呈负相关性,有拮抗纤维化的作用;②AT1可改善气道重塑过程,可能是通过升高气道HGF水平达到抗纤维化的作用。 Objective To study the effect of valsatan (angiotensin 11 receptor antagonist, ATI ) on hepatoeyte growth factor (HGF) in the airways and airway remodeling in asthmatic rats. Methods Thirty-two rats were randomly assigned into A - D four groups. Group A was normal control without treatment. Groups B-D were challenged by ovalbumin (OVA) for 2 weeks, 4 weeks and 4 weeks respectively to induce asthma. Group D received intragastric admiuistratioll uf valsatan (30 μg/kg daily for 4 weeks) after OVA challenge. The expressions of HGF, angiotunin II (Angll) and transforming growth factor ( TGF-β1 ) in the airways were detected by immunihistoehemical staining, The pathological changes uf airways were observed hy Haematoxylin & Eosin staining. Results The HGF expression of Group B was significantly higher than that of Group A ( 10. 69 ±0. 96% vs 5.49 ± 1,34% ; P 〈0.05 ), Group C also showed an increased HGF level ( 11.85 ± 0. 87% ) compared with Group A (P 〈0. 05 ), The HGF level in Group D ( 15.58± 1. 06% ) was significantly higer than that of both Group B and Group C (P 〈0. 05 ), The expressions of TGF-β1 and Angll increased with the challenged time, while valsatan treatment decreased significantly the levels of both, Valsatan treatment attenuated airway injuries of asthmatic rats induced by OVA sensitization/challenge, Conclusions HGF has protective effects on airways and anti-fibrotic effects. Valsatan can improve airway remodeling possibly by increasing HGF levels in asthmatic rats,
作者 栾斌 宋丽
出处 《中国当代儿科杂志》 CAS CSCD 2006年第6期482-485,共4页 Chinese Journal of Contemporary Pediatrics
关键词 缬沙坦 肝细胞生长因子 气道重塑 转化生长因子 大鼠 Valsatan Hepatocyte growth factor Airway remodeling Transforming growth factor Rats
  • 相关文献

参考文献4

二级参考文献27

  • 1[1]Tonnel AB,Gosset P,Molet S,et al.Interactions between endothelial cells and effector cells in allergic inflammation[J].Ann N Y Acad Sci,1996,796:9-20.
  • 2[2]Teran LM,Carrol MP,Frew AJ,et al.Leukocyte recruitment after local endobronchial allergen chellenge in asthma.Relationship to procedure and to airway interleukin-8 release[J].Am J Respir Crit Care Med,1996,154 (2 pt 1):469-476.
  • 3[3]Chanez P,Enander I,Jones I,et al.Interleukin 8 in bronchoalveolar lavage of asthmatic and chronic bronchitis patients[J].Int Arch Allergy Immunol,1996,111 (1):83-88.
  • 4[4]Keatings VM,Collins PD,Scott DM,et al.Differences in interleukin-8 and tumor necrosis factor-alpha in induced sputum from patients with chronic obstructive pulmonary disease or asthma[J].Am J Respir Care Med,1996,153(2):530-534.
  • 5[5]Nocker RE,Schoonbrood DF,Graaf EA,et al.Interleukin-8 in airway inflammation in patients with asthma and chronic obstructive pulmonary disease[J].Int Arch Allergy Immunol,1996,109 (2):183-191.
  • 6[6]Gelder CM,Thomas PS,Yates DH,et al.Cytokine expression in normal,atopic,and asthmatic subjects using the combination of sputum induction and the polymerase chain reaction[J].Thorax,1995,50 (10):1033-1037.
  • 7[7]Opal SM,Wherry JC,Grint P.Interleukin-1O:potential benefits and possible risks in clinical infectious diseases[J].Clin Infect Dis,1998,27(6):1497-1507.
  • 8[8]Stordeur P,Goldman M.Interleukin-1O as a regulatory cytokine induced by cellular stress:molecular aspects[J].Inter Rev Immunol,1998,16(2):501-522.
  • 9[9]Koning H,Neijens HJ,Baert MR,et al.T cells subsets and cytokines in allergic and non-allergic children.Ⅱ.Analysis and IL-5 and IL-10-mRNA expression and protein production[J].Cytokine,1997,9 (6):427-436.
  • 10[10]Takanashi S,Hasegawa Y,Kanehira Y,et al.Interleukin-1O level in sputum is reduced in bronchial asthma,COPD and in smokers[J].Eur Respir J,1999,14(2):309-314.

共引文献19

同被引文献37

引证文献3

二级引证文献6

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部